[1] 李晓强, 张福先, 王深明. 深静脉血栓形成的诊断和治疗指南(第三版)[J]. 中国血管外科杂志:电子版, 2017, 32(9):807-812. [2] RASKOB G. Thrombosis: a major contributor to global disease burden[J]. Thromb Res, 2014, 111(5):843-852. [3] 刘亚群, 韩东岳, 程兆忠. Caprini和Pauda风险评估模型联合使用对筛选内科住院患者静脉血栓栓塞症的应用价值[J]. 中华临床医师杂志:电子版, 2019, 13(2):120-123. [4] XIA Z H, CHEN W H, WANG Q. Risk factors for venous thromboembolism following surgical treatment of fractures: a systematic review and meta-analysis[J]. Int Wound J, 2023, 20(4):895-1332. [5] ORTEL T L, NEUMANN I, AGENO W, et al. American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism[J]. Blood Adv, 2020, 4(19):4693-4738. [6] KALRA S, SHARMA S K. Diabetes in the elderly[J]. Diabetes Ther, 2018, 9(2):493-500. [7] 王莹, 白映雪. 不同气压治疗方案对预防老年糖尿病患者下肢深静脉血栓的应用效果[J]. 血栓与止血学, 2022, 28(3):494-495. [8] GOULD M K, GARCIA D A, WREN S M, et al. Prevention of VTE in nonorthopedic surgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines[J]. Chest, 2012, 141(2 Suppl):e227S-e277S. [9] CAPRINI J A. Thrombosis risk assessment as a guide to quality patient care[J]. Dis Mon, 2005, 51(2/3):70-78. [10] PANG H, WANG L, LIU J, et al. The prevalence and risk factors of venous thromboembolism in hospitalized patients with acute exacerbation of chronic obstructive pulmonary disease[J]. Clin Respir J, 2018, 12(11):2573-2580. [11] FU Y, LIU Y, CHEN S, et al. The combination of Caprini risk assessment scale and thrombotic biomarkers to evaluate the risk of venous thromboembolism in critically ill patients[J]. Medicine, 2018, 97(47):e13232. [12] 周迎, 任利辉, 陈策, 等. Caprini风险评估模型筛选老年急性心力衰竭患者静脉血栓栓塞症的有效性分析[J]. 中国血管外科杂志:电子版, 2022, 14(4):343-347. [13] 中华医学会呼吸病学分会肺栓塞与肺血管病学组, 中国医师协会呼吸医师分会肺栓塞与肺血管病工作委员会, 全国肺栓塞与肺血管病防治协作组. 肺血栓栓塞症诊治与预防指南[J]. 中华医学杂志, 2018, 98(14):1060-1087. [14] TRITSCHLER T, AUJESKY D. Venous thromboembolism in the elderly: a narrative review[J]. Thromb Res, 2017, 155:140-147. [15] DENG W, HUO L, YUAN Q, et al. Risk factors for venous thromboembolism in patients with diabetes undergoing joint arthroplasty[J]. BMC Musculoskelet Disord, 2021, 22(1):608. [16] FENG Y, ZHENG R, FU Y, et al. Assessing the thrombosis risk of peripherally inserted central catheters in cancer patients using Caprini risk assessment model: a prospective cohort study[J]. Support Care Cancer, 2021, 29(9):5047-5055. [17] GOLD P A, NG T Y, COURY J R, et al. Can the Caprini score predict thromboembolism and guide pharmacologic prophylaxis after primary joint arthroplasty?[J]. J Orthop, 2020, 21:345-349. [18] HASLEY R B, ALY S, CARTER C O, et al. Application of the Caprini risk assessment model to select patients for extended thromboembolism prophylaxis after sleeve gastrectomy[J]. J Gastrointest Surg, 2022, 26(2):298-304. [19] D'ASTOUS J, LIEDERMAN Z, DOUKETIS J D. Venous thromboembolism prophylaxis in high-risk orthopedic and cancer surgery[J]. Postgrad Med, 2021, 133(1):20-26. [20] KERAMIDAS G, GOURGOULIANIS K I, KOTSIOU O S. Venous thromboembolic disease in chronic inflammatory lung diseases: knowns and unknowns[J]. J Clin Med, 2021, 10(10):2061. [21] 赵静. Caprini静脉血栓风险评估表在呼吸科住院患者中的使用价值[J]. 中国实验诊断学, 2021, 25(1):19-22. [22] 白冬波. 慢性阻塞性肺疾病急性加重期并发静脉血栓栓塞症的危险因素及预防[J]. 血栓与止血学, 2016, 22(3):270-272. [23] ARTIFONI M, DANIC G, GAUTIER G, et al. Systematic assessment of venous thromboembolism in COVID-19 patients receiving thromboprophylaxis: incidence and role of D-dimer as predictive factors[J]. J Thromb Thrombolysis, 2020, 50(1):211-216. |